GLP‑1 improves palmitate‑induced insulin resistance in human skeletal muscle via SIRT1 activity

  • Authors:
    • Ja Young Jeon
    • Sung‑E Choi
    • Eun Suk Ha
    • Han Byeol Lee
    • Tae Ho Kim
    • Seung Jin Han
    • Hae Jin Kim
    • Dae Jung Kim
    • Yup Kang
    • Kwan‑Woo Lee
  • View Affiliations

  • Published online on: July 9, 2019     https://doi.org/10.3892/ijmm.2019.4272
  • Pages: 1161-1171
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study investigated whether glucagon like peptide‑1 (GLP‑1) improves glucose uptake through glucose transporter type 4 (GLUT4), mediated by the activation of sirtuin 1 (SIRT1), in skeletal muscle cells with palmitate induced‑insulin resistance. The levels of glucose uptake, GLUT4, protein kinase A (PKA), and cyclic adenosine monophosphate (cAMP) were determined in human skeletal muscle myotubes (HSMMs) exposed to palmitate and GLP‑1. Then, to determine whether PKA/cAMP were downstream signals of GLP‑1, a PKA inhibitor was used. To determine whether SIRT‑1 contributes to GLP‑1 action in HSMMs with palmitate‑induced insulin resistance, the levels of peroxisome proliferator‑activated receptor γ coactivator 1α (PGC1α) deacetylation and SIRT‑1 activity were assessed using a SIRT1 inhibitor and small interfering RNA (siRNA). The phosphorylation levels of protein kinase B (Akt) and insulin receptor substrate 1 (IRS‑1) as insulin signaling pathways, were assessed in GLP‑1‑treated HSMMs exposed to palmitate. The influence of SIRT1 on the GLP‑1‑induced activation of insulin signaling pathway was determined using a SIRT1 inhibitor. GLP‑1 restored the palmitate‑induced reductions in the levels of glucose uptake, GLUT4 mRNA, GLUT4 promoter activity, and GLUT4 protein in HSMMs. PKA and cAMP, as GLP‑1 downstream signals, played a role in this process. GLP‑1 increased the deacetylation levels of PGC1α, and stimulated SIRT1 in HSMMs. Moreover, the SIRT1 inhibitor and siRNA of SIRT1 suppressed the effect of GLP‑1 on GLUT4 expression in HSMMs exposed to palmitate. The SIRT1 inhibitor also prevented the GLP‑1‑induced phosphorylation of IRS‑1 and Akt in palmitate‑treated HSMMs. The present findings suggest that in palmitate‑induced insulin‑resistant HSMM, GLP‑1 activates SIRT1 through the PKA/cAMP pathway, which in turn enhances glucose uptake through GLUT4 and the insulin signaling pathway.
View Figures
View References

Related Articles

Journal Cover

September 2019
Volume 44 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Jeon, J.Y., Choi, S., Ha, E.S., Lee, H.B., Kim, T.H., Han, S.J. ... Lee, K. (2019). GLP‑1 improves palmitate‑induced insulin resistance in human skeletal muscle via SIRT1 activity. International Journal of Molecular Medicine, 44, 1161-1171. https://doi.org/10.3892/ijmm.2019.4272
MLA
Jeon, J. Y., Choi, S., Ha, E. S., Lee, H. B., Kim, T. H., Han, S. J., Kim, H. J., Kim, D. J., Kang, Y., Lee, K."GLP‑1 improves palmitate‑induced insulin resistance in human skeletal muscle via SIRT1 activity". International Journal of Molecular Medicine 44.3 (2019): 1161-1171.
Chicago
Jeon, J. Y., Choi, S., Ha, E. S., Lee, H. B., Kim, T. H., Han, S. J., Kim, H. J., Kim, D. J., Kang, Y., Lee, K."GLP‑1 improves palmitate‑induced insulin resistance in human skeletal muscle via SIRT1 activity". International Journal of Molecular Medicine 44, no. 3 (2019): 1161-1171. https://doi.org/10.3892/ijmm.2019.4272